Artemis Medicare Services Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Artemis Medicare Services Limited generated cash of $1,088,544,000, which is less than the previous year. Cash used in financing activities reached the amount of -$301,241,000 last year. Net change in cash is therefore -$82,598,000.
Cash Flow
| 2016 | 741.89K | 500K | -242.97M |
|---|---|---|---|
| 2018 | 766.03M | -680.11M | -134.52M |
| 2020 | 460.47M | -259.17M | -177.61M |
| 2021 | 182.38M | -378.46M | 271.61M |
| 2023 | 1.12B | -1.57B | 521.81M |
| 2024 | 1.08B | -891.04M | -301.24M |
ARTEMISMED.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 228.68M | 156.98M | 116.08M | 92.38M | 90.66M | 216.16M |
Operating activities | ||||||
Net income | 491.40M | 385.97M | 64.85M | 197.92M | 262.76M | 728.66K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 403.16M | 310.04M | 215.13M | 226.30M | 188.05M | 120.64M |
Stock-based compensation expense | 21.75M | 40.30M | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 21.75M | 40.30M | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -37.10M | -218.27M | 191.13M | 7.72M | 49.94M | -146.39M |
Inventories | 39.08M | -15.94M | 11.29M | -38.16M | -520K | 10.58M |
Accounts payable | 74.90M | 290.92M | -164.88M | 15.30M | 0 | 0 |
Cash generated by operating activities | 1.08B | 1.12B | 182.38M | 460.47M | 766.03M | 741.89K |
Investing activities | ||||||
Purchases Of Investments | 0 | -160.74M | -79.13M | -9.00M | -69.68M | 0 |
Investments In Property Plant And Equipment | -725.53M | -1.46B | -345.01M | -260.03M | -613.28M | -167.10M |
Acquisitions Net | 21.09M | 48.30M | 45.67M | 9.86M | 2.86M | 0 |
Cash generated by investing activities | -891.04M | -1.57B | -378.46M | -259.17M | -680.11M | 500K |
Financing activities | ||||||
Common Stock Issued | 1.74M | 1.74M | 0 | 0 | 0 | 0 |
Payments for dividends | -61.13M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 81.44M | 552.82M | -295.87M | 92.28M | -22.73M | -168.57M |
Cash used in financing activities | -301.24M | 521.81M | 271.61M | -177.61M | -134.52M | -242.97M |
Net Change In Cash | -82.59M | 71.69M | 75.53M | 23.69M | -46.04M | -214.85M |
Cash at end of period | 146.08M | 228.68M | 191.62M | 116.08M | 44.62M | 1.30M |
| Data source | Data source | Data source | Data source | Data source | Data source |